Vitamin-C-megaskorbicka-liecba.pdf - Zdravie.sk

Vitamín C a megaskorbická liečba – zabudnutý poklad 406 / 436
Zdroje
[1444] Hanck A. Tolerance and effects of high doses of ascorbic acid. Dosis facit venenum. Int J Vitam Nutr Res
Suppl. 1982;23:221-38. PMID:6811482.
[1445] Thomas MR, Sneed SM, Wei C, Nail PA, Wilson M, Sprinkle EE 3rd. The effects of vitamin C, vitamin B6,
vitamin B12, folic acid, riboflavin, and thiamin on the breast milk and maternal status of well-nourished
women at 6 months postpartum. Am J Clin Nutr. 1980 Oct;33(10):2151-6. PMID:7424809.
http://www.ajcn.org/cgi/reprint/33/10/2151
[1446] Sneed SM, Zane C, Thomas MR. The effects of ascorbic acid, vitamin B6, vitamin B12, and folic acid
supplementation on the breast milk and maternal nutritional status of low socioeconomic lactating women. Am
J Clin Nutr. 1981 Jul;34(7):1338-46. PMID:7258124. http://www.ajcn.org/cgi/reprint/34/7/1338
[1447] Byerley LO, Kirksey A. Effects of different levels of vitamin C intake on the vitamin C concentration in
human milk and the vitamin C intakes of breast-fed infants. Am J Clin Nutr. 1985 Apr;41(4):665-71.
PMID:3984919. http://www.ajcn.org/cgi/reprint/41/4/665
[1448] Marks J. The safety of the vitamins: an overview. Int J Vitam Nutr Res Suppl. 1989;30:12-20.
PMID:2507691.
[1449] Samborskaia EP, Ferdman TD. [Mechanism of abortion induced by ascorbic acid]. Biull Eksp Biol Med.
1966 Aug;62(8):96-8. PMID:6005485.
[1450] Hornig DH, Moser U (1981). The safety of high vitamin C intake in man. In: J. N. Counsell & D. H. Hornig,
Vitamin C (pp. 225-248). London: Applied Science Publishers.
[1451] Greer E. Vitamin C in Acute Poliomyelitis: Med Times. 1955 Nov;83(11):1160-1. PMID:13279345.
http://www.seanet.com/~alexs/ascorbate/195x/greer-e-medical_times-1955-v83-n11-p1160.htm
[1452] Baetgen D. [Results of treatment of epidemic hepatitis in childhood with high doses of ascorbic acid in the
years 1957-58.] Med Monatsschr. 1961 Jan;15:30-6. PMID:13685819.
[1453] Poser E. Large ascorbic acid intake. N Engl J Med. 1972 Aug 24;287(8):412-3. PMID:5043534.
[1454] Boines GJ. A rationale for the use of hesperidin and ascorbic acid in the management of poliomyelitis. Ann
N Y Acad Sci. 1955 Jul 8;61(3):721-5; discussion, 725-8. PMID:13249308. DOI:10.1111/j.1749-
6632.1955.tb42526.x.
[1455] Montandon JA, De Rezende GL. Folha Med. 1977;74:459-62.
[1456] Bali L, Callaway E. Vitamin C and migraine: a case report. N Engl J Med. 1978 Aug 17;299(7):364.
PMID:355884.
[1457] Banic S, Korsak M.: In: Hanck A, Ritzel G. (Edit). "Vitamin C. Recent advances and aspects in virus disease,
cancer and lipid metabolism", p. 35. ff. Hans Huber, Bern 1979.
[1458] Hohenfellner R. Therapiewoche 1970;29:1429-30,1432-4.
[1459] Rosenthal G. Interaction of ascorbic acid and warfarin. JAMA. 1971 Mar 8;215(10):1671. PMID:5107696.
[1460] Smith EC, Skalski RJ, Johnson GC, Rossi GV. Interaction of ascorbic acid and warfarin. JAMA. 1972 Sep
4;221(10):1166. PMID:4679014.
[1461] Hume R, Johnstone JM, Weyers E. Interaction of ascorbic acid and warfarin. JAMA. 1972 Mar
13;219(11):1479. PMID:5066913.
[1462] Feetam CL, Leach RH, Meynell MJ. Lack of a clinically important interaction between warfarin and
ascorbic acid. Toxicol Appl Pharmacol. 1975 Mar;31(3):544-7. PMID:1145638.
[1463] Cunningham JJ, Ellis SL, McVeigh KL, Levine RE, Calles-Escandon J. Reduced mononuclear leukocyte
ascorbic acid content in adults with insulin-dependent diabetes mellitus consuming adequate dietary vitamin
C. Metabolism. 1991 Feb;40(2):146-9. PMID:1988772.
[1464] Davie SJ, Gould BJ, Yudkin JS. Effect of vitamin C on glycosylation of proteins. Diabetes. 1992
Feb;41(2):167-73. PMID:1733805.
[1465] Ceriello A, Giugliano D, Quatraro A, Donzella C, Dipalo G, Lefebvre PJ. Vitamin E reduction of protein
glycosylation in diabetes. New prospect for prevention of diabetic complications? Diabetes Care. 1991
Jan;14(1):68-72. PMID:1991440.
[1466] Cunningham JJ, Mearkle PL, Brown RG. Vitamin C: an aldose reductase inhibitor that normalizes
erythrocyte sorbitol in insulin-dependent diabetes mellitus. J Am Coll Nutr. 1994 Aug;13(4):344-50.
PMID:7963139.
[1467] Vinson JA, Staretz ME, Bose P, Kassm HM, Basalyga BS. In vitro and in vivo reduction of erythrocyte
sorbitol by ascorbic acid. Diabetes. 1989 Aug;38(8):1036-41. PMID:2753234.
[1468] Wang H, Zhang ZB, Wen RR. [Reduction of erythrocyte sorbitol by ascorbic acid in patients with diabetes
mellitus] [Article in Chinese] Zhonghua Yi Xue Za Zhi. 1994 Sep;74(9):548-51, 583. PMID:7842354.
[1469] Wang H, Zhang ZB, Wen RR, Chen JW. Experimental and clinical studies on the reduction of erythrocyte
sorbitol-glucose ratios by ascorbic acid in diabetes mellitus. Diabetes Res Clin Pract. 1995 Apr;28(1):1-8.
PMID:7587907.
[1470] Urberg M, Zemel MB. Evidence for synergism between chromium and nicotinic acid in the control of
glucose tolerance in elderly humans. Metabolism. 1987 Sep;36(9):896-9. PMID:3626867.
[1471] Reimers JI, Andersen HU, Pociot F. [Nicotinamide and prevention of insulin-dependent diabetes mellitus.
Rationale, effects, toxicology and clinical experiences. ENDIT Group] [Article in Danish] Ugeskr Laeger. 1994
Jan 24;156(4):461-5. PMID:8140661.
[1472] Elliott RB, Chase HP. Prevention or delay of type 1 (insulin-dependent) diabetes mellitus in children using
nicotinamide. Diabetologia. 1991 May;34(5):362-5. PMID:1830860.
[1473] Behme MT. Nicotinamide and diabetes prevention. Nutr Rev. 1995 May;53(5):137-9. PMID:7666987.
[1474] European Nicotinamide Diabetes Intervention Trial Group. Intervening before the onset of Type 1
diabetes: baseline data from the European Nicotinamide Diabetes Intervention Trial (ENDIT). Diabetologia.
2003 Mar;46(3):339-46. Epub 2003 Feb 27. PMID:12687331. DOI:10.1007/s00125-003-1033-8.